Provention Bio, Inc.
PRVB · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $789,822 | $354,628 | $888,622 | $607,130 |
| - Cash | $44,039 | $78,190 | $102,294 | $39,165 |
| + Debt | $23,910 | $590 | $715 | $0 |
| Enterprise Value | $769,693 | $277,028 | $787,043 | $567,965 |
| Revenue | $12,895 | $1,395 | $0 | $0 |
| % Growth | 824.4% | – | – | – |
| Gross Profit | $12,383 | $1,395 | $0 | $0 |
| % Margin | 96% | 100% | – | – |
| EBITDA | -$124,692 | -$115,191 | -$99,654 | -$44,372 |
| % Margin | -967% | -8,257.4% | – | – |
| Net Income | -$113,565 | -$114,432 | -$98,581 | -$42,198 |
| % Margin | -880.7% | -8,203% | – | – |
| EPS Diluted | -1.52 | -1.81 | -1.88 | -1.04 |
| % Growth | 16% | 3.7% | -80.8% | – |
| Operating Cash Flow | -$75,408 | -$95,385 | -$76,336 | -$36,065 |
| Capital Expenditures | -$795 | -$961 | -$1,111 | $0 |
| Free Cash Flow | -$76,203 | -$96,346 | -$77,447 | -$36,065 |